Related Experiment Videos
Myasthenia gravis improvement after laparoscopic Roux-en-Y gastric bypass
Fernando Arias1, Samuel Szomstein, Lester Carrodeguas
1The Bariatric Institute, Department of Neurology, Cleveland Clinic Florida, Weston, FL 33331, USA.
Obesity Surgery
|June 11, 2005
Summary
Weight loss surgery improved myasthenia gravis (MG) symptoms in a morbidly obese patient. The patient required fewer medications post-surgery, highlighting the benefits of bariatric procedures for complex conditions.
Area of Science:
- Medical Case Study
- Bariatric Surgery
- Neuromuscular Disorders
Background:
- Morbid obesity and myasthenia gravis (MG) present significant perioperative challenges.
- Obesity is linked to numerous comorbidities that can worsen with MG.
- Management requires a careful, multidisciplinary approach.
Observation:
- A 56-year-old female with a history of MG and morbid obesity (BMI 46.5 kg/m2) was evaluated.
- The patient was on multiple medications, including IV immunoglobulin for MG management.
- She underwent a surgical procedure for weight loss.
Findings:
- Post-surgery, the patient experienced significant improvement in her MG symptoms.
- Medication requirements, including IV immunoglobulin, were reduced after the bariatric procedure.
- Weight loss positively impacted the management of her chronic neuromuscular condition.
Implications:
- Bariatric surgery can lead to substantial improvements in patients with co-existing morbid obesity and myasthenia gravis.
- Successful weight loss may decrease the burden of MG treatment and improve quality of life.
- This case underscores the importance of a comprehensive, multidisciplinary strategy for managing patients with complex comorbidities.